CHRNA7 and schizophrenia: Experimental application of α7 nAChR agonists can be beneficial in schizophrenia treatment e.g., Tregellas et al. successfully tested 3-(2,4-dimethoxybenzylidene) anabaseine as a α7 nAChR agonist [51].